GHK-Cu, the copper complex of the tripeptide glycyl-L-histidyl-L-lysine, is among the most-cited small peptides in tissue-biology research. Earlier literature focused on wound-healing and collagen assays. Over the last decade, attention shifted to a different kind of evidence: large-scale gene-expression analyses that ask how many genes the peptide appears to influence and in which direction. This article reviews what those analyses report, and, just as importantly, what kind of evidence they are. For the general compound background, see our GHK-Cu research overview.
Origin of the Molecule
GHK was first isolated from the albumin fraction of human plasma by Pickart and Thaler, who reported in 1973 that it stimulated survival of normal liver cells in culture (Nature New Biology 1973;243:85-87). GHK has a high affinity for copper(II) and circulates in plasma largely as the GHK-Cu complex. Pickart's later work reported that plasma GHK concentrations decline with age, a claim that has shaped much of the interest in the molecule and which depends on the assay methods in that body of work.
The Tissue-Culture Foundation
Before transcriptomics, the evidence was mainly cellular. Maquart and colleagues reported that GHK-Cu stimulated collagen synthesis in fibroblast cultures (FEBS Lett 1988;238:343-346). Pickart, Vasquez-Soltero and Margolina later reviewed the skin-regeneration literature, summarizing reports on extracellular-matrix synthesis, metalloproteinase modulation, and antioxidant effects (BioMed Res Int 2015;2015:648108). These studies are largely in vitro or in animal wound models.
The Connectivity Map Analyses
The gene-expression papers rely substantially on the Connectivity Map (cMap), a Broad Institute resource that catalogs gene-expression changes in a handful of cultured human cell lines after treatment with several thousand small molecules, typically at a single standard concentration. In 2018, Pickart and Margolina published an analysis in the International Journal of Molecular Sciences (2018;19(7):1987) examining cMap data for GHK. They reported that GHK altered the expression of a large number of genes, with a bias toward restoring expression patterns associated with healthier states in their comparisons, including reported effects on genes linked to tissue remodeling, antioxidant defense, and DNA repair, and the opposite direction of change in genes tied to disease signatures in the datasets examined. A follow-up paper applied the same approach to nervous-system function, reporting that GHK shifted expression of genes relevant to neuronal function and to signatures associated with cognitive decline (Pickart, Vasquez-Soltero and Margolina, Brain Sci 2017;7(2):20).
How to Read This Kind of Evidence
These analyses are interesting hypothesis-generators, but they have well-understood limits:
- They are in silico comparisons of existing data. The authors compared expression signatures from cMap; they did not run a new, independently designed experiment in primary tissue.
- Cell-line context. cMap uses a small number of immortalized or cancer-derived cell lines. Responses in a cell line may not reflect responses in intact tissue.
- Single-concentration, short-exposure design. The platform was not built to model dose-response or chronic exposure.
- Counting genes is not counting biology. A statement that a molecule changes a large fraction of the genome depends on the thresholds chosen. Many small changes may reflect general stress or copper-handling responses and not specific signaling.
- Replication. Much of this work comes from a small group of authors with a long history on the molecule. Independent replication with new datasets would strengthen it.
Practical Considerations for Researchers
- Peptide versus complex. GHK and GHK-Cu are different reagents. Copper itself is redox-active and can influence cell-culture outcomes independently of the peptide, so a free-copper control and a GHK-without-copper control are good practice.
- Medium composition. Serum and chelating components in culture medium can bind copper and shift free-copper levels, which changes effective exposure.
- Orthogonal validation. If a transcriptomic hit matters, confirm by qPCR and, where possible, at the protein level.
What Is and Is Not Established
Established: GHK-Cu is a naturally occurring copper-binding tripeptide with reproducible effects on collagen and extracellular-matrix synthesis in fibroblast assays. Reported but not independently settled: the breadth of its gene-expression effects and their direction. Not established by this literature: any clinical or therapeutic effect in humans from the gene-expression data alone.
Sources
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci 2018;19(7):1987. PubMed
- Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci 2017;7(2):20.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Res Int 2015;2015:648108.
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver cells. Nat New Biol 1973;243:85-87.
- Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett 1988;238:343-346.
For research use only. Not for human or veterinary consumption. This article is educational and describes published literature; it makes no claims about the use of any product.